Evidence map›Paper›PMID 35929572›Full record

ArticleThe British journal of dermatology2022

Melanoma overdiagnosis: why it matters and what can be done about it.

Katy J L Bell, Tamar Nijsten

Abstract readComment
In one paragraph

Article in The British journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. A Clinical Perspective on Melanoma Overdiagnosis.The Australasian journal of dermatology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Debunking myths about screening: How to screen more judiciously.Canadian family physician Medecin de famille canadien · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Katy J L BellSydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Edward Ford Building (A27), Camperdown, Sydney, NSW, 2006, Australia.ORCID 0000-0002-0137-3218
Tamar NijstenDepartment of Dermatology, Erasmus MC Cancer Institute, Doctor Molewaterplein 40, 3015, GD, Rotterdam, the Netherlands.ORCID 0000-0001-9940-2875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medical OveruseMelanomaEarly Detection of CancerHumansMass ScreeningSyndrome

Identifiers

PMID35929572
PMCPMC9805151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.